Van Lanschot Kempen Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295K | Sell |
663
-35
| -5% | -$15.6K | ﹤0.01% | 233 |
|
|
2025
Q1 | $338K | Sell |
698
-2,682
| -79% | -$1.3M | ﹤0.01% | 218 |
|
|
2024
Q4 | $1.36M | Sell |
3,380
-59
| -2% | -$23.8K | 0.01% | 208 |
|
|
2024
Q3 | $1.6M | Sell |
3,439
-247
| -7% | -$115K | 0.02% | 185 |
|
|
2024
Q2 | $1.73M | Sell |
3,686
-1,000
| -21% | -$469K | 0.02% | 188 |
|
|
2024
Q1 | $1.96M | Sell |
4,686
-1,847
| -28% | -$772K | 0.02% | 179 |
|
|
2023
Q4 | $2.66M | Sell |
6,533
-1,206
| -16% | -$491K | 0.04% | 170 |
|
|
2023
Q3 | $2.69M | Sell |
7,739
-1,276
| -14% | -$444K | 0.05% | 147 |
|
|
2023
Q2 | $3.17M | Sell |
9,015
-3,710
| -29% | -$1.31M | 0.06% | 147 |
|
|
2023
Q1 | $4.01M | Buy |
12,725
+797
| +7% | +$251K | 0.08% | 135 |
|
|
2022
Q4 | $3.44M | Buy |
11,928
+1,154
| +11% | +$333K | 0.1% | 127 |
|
|
2022
Q3 | $3.12M | Sell |
10,774
-605
| -5% | -$175K | 0.13% | 116 |
|
|
2022
Q2 | $3.21M | Buy |
11,379
+440
| +4% | +$124K | 0.12% | 119 |
|
|
2022
Q1 | $2.86M | Buy |
10,939
+10,694
| +4,365% | +$2.79M | 0.09% | 128 |
|
|
2021
Q4 | $54K | Hold |
245
| – | – | ﹤0.01% | 181 |
|
|
2021
Q3 | $44K | Buy |
245
+30
| +14% | +$5.39K | ﹤0.01% | 194 |
|
|
2021
Q2 | $43K | Buy |
+215
| New | +$43K | ﹤0.01% | 195 |
|